Kato Goro, Maeda Shuichiro
Department of Biochemistry, Yamanashi Medical University, Nakakoma, Yamanashi 409-3898, Japan.
J Biochem. 2003 May;133(5):563-9. doi: 10.1093/jb/mvg072.
c-Src-null mutants have not provided a full understanding of the cellular functions of c-Src, reflecting the functional redundancy among Src family members. c-Src is phosphorylated by cyclin-dependent kinase 1 (Cdk1) and Cdk5 at Ser75 in the unique amino terminal c-Src-specific domain. The specific roles of c-Src may be assessed by establishing mouse embryonic stem (ES) cells homozygous for a point mutation at Ser75. Mammalian homozygous cultured cells with a point mutation, however, have not yet been produced by gene targeting. Here we show an efficient procedure for producing ES cell clones bearing a homozygous Ser75 to Asp mutation in the c-src gene. This procedure was developed by combining two previously reported strategies: our procedure for introducing a point mutation into one allele with no exogenous sequence, and the high-geneticin (G418) selection procedure for introducing a mutation into both alleles. The mutant clones expressed the same levels of c-Src protein and autophosphorylation activity as wild-type cells, but the mutant c-Src was not phosphorylated on Ser75 during mitosis. This procedure is feasible for generating cells homozygous for a subtle mutation in most genes, and is expected to be applicable to other somatic cell lines.
c-Src基因敲除突变体尚未完全揭示c-Src的细胞功能,这反映了Src家族成员之间的功能冗余。在c-Src特有的独特氨基末端结构域中,c-Src在Ser75位点被细胞周期蛋白依赖性激酶1(Cdk1)和Cdk5磷酸化。c-Src的特定作用可通过构建Ser75位点发生点突变的纯合小鼠胚胎干细胞(ES细胞)来评估。然而,通过基因打靶尚未产生具有点突变的哺乳动物纯合培养细胞。在此,我们展示了一种高效的方法,可产生c-src基因中携带Ser75突变为Asp的纯合突变的ES细胞克隆。该方法是通过结合两种先前报道的策略开发而成:我们将点突变引入一个等位基因且无外源序列的方法,以及将突变引入两个等位基因的高遗传霉素(G418)选择方法。突变克隆表达的c-Src蛋白水平和自身磷酸化活性与野生型细胞相同,但在有丝分裂期间,突变的c-Src在Ser75位点未被磷酸化。该方法对于生成大多数基因中微小突变的纯合细胞是可行的,并且有望应用于其他体细胞系。